Back to Search

A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma

  • Protocol Number: 202510224
  • Principal Investigator: Trikalinos, Nikolaos
  • Cancer Types: Gastrointestinal

Learn more about this study at: clinicaltrials.gov

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).

Protocol Interventions

Drug: ONC206: Dose 2